FIELD: organic synthesis. SUBSTANCE: trans-6- [substituted pyrrol-1-yl)alkyl]pyran-2-on derivatives having general formula I: (I), wherein R1 is phenyl optionally substituted by fluorine, bromine, or chlorine; R2 and R3 are hydrogen, alkyl, phenyl or radical -CONR5R6, in which R5 and R6 are hydrogen, alkyl, or phenyl optionally substituted by fluorine, chlorine, or bromine; and R4 is C1-6- alkyl, are prepared with compound of formula II () with compound of formula III () followed by interaction of resulting intermediate having formula IV (NC-CH2CH-CH2-CO-CH2-CONR8R9) with R10
2
BOCH3 or R10
2
B and then with borane in solvent. Resulting compound NC-CH2CH-CH2-CO-CH2-CONR8R9 is brought into reaction with reagent R11R12C(OCH3)2 or R11R12CO under acid conditions. Resulting ketal having formula V () is hydrogenated and brought into reaction with compound R1COCHR2CHR3COR4 to give intermediate VI (), which is treated with acid in solvent and hydrolyzed with base to give intermediate that, after neutralization with acid and dissolution in solvent with simultaneous removal of water, is converted into final product. EFFECT: increased yield and reduced expenses on reagents. 14 cl, 2 dwg, 6 ex
Title |
Year |
Author |
Number |
METHOD OF SYNTHESIS OF 6-CYANOMETHYL-2,2-DIMETHYL-1,3-DIOXANE-4-ACETIC ACID (4R-CIS)-1,1-DIMETHYLETHYL ESTER |
1991 |
- Ehlen Millar[Gb]
- Donel'D Judzhin Batler[Us]
|
RU2067580C1 |
SULFAMIC ACID ESTERS, PHARMACEUTICAL COMPOSITION FOR CONTROL OF CHOLESTEROL CONCENTRATION, METHOD OF TREATMENT OF PATIENTS WITH HYPERCHOLESTEROLEMIA, METHOD OF TREATMENT OF PATIENTS WITH ATHEROSCLEROSIS |
1994 |
- Khelen Tsenvej Li
- Dzhozef Armend Pikard
- Drago Robert Sliskovits
- Vendell Virendzhe
|
RU2137756C1 |
METHOD OF SYNTHESIS OF (S)-(-)- AND (R)-(+)-ISOMERS OF (5-AMINO-1,2-DIHYDRO-2-METHYL-3-PHENYLPYRIDO-[3,4-B]-PYRAZINE- -7-YL)-CARBAMIDE ACID ETHYL ESTER OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND INTERMEDIATE (S)-(-)- AND (R)-(+)-ISOMERS OF [6-AMINO-4-[[2-(ALKOXYALKYLAMINO)-1-METHYL-2-OXOETHYL]-AMI- -NO]-5-NITRO-2-PYRIDINYL]-CARBAMIDE ACID ETHYL ESTER |
1994 |
- Om Prakash Goehl[Us]
- Sham Shridkhar Nikam[In]
|
RU2098409C1 |
NEW METHOD FOR PREPARING 5-(4-FLUOROPHENYL)-1-[2-(2R,4R)-4-HYDROXY-6-OXOTETRAHYDROPYRAN-2-YL)ETHYL]-2-ISOPROPYL-4-PHENYL-1H-PYRROL-3-CARBOXYLI9C ACID PHENYLAMIDE |
2001 |
- Batler Donal'D Judzhin
- Dedzhong Rehndoll Li
- Nel'Son Dzhejd Duglas
- Pammen Majkl Zherar
- Stak Timoti Li
|
RU2244714C1 |
METHOD FOR INHIBITING EPIDERMAL GROWTH FACTOR RECEPTOR THYROSINEKINASE, NITROGEN-CONTAINING TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION FOR INTRODUCING EPIDERMAL GROWTH FACTOR RECEPTOR THYROSINEKINASE INHIBITOR LIKE ERB- B2, ERB-B3 OR ERB-B4 AND CONTRACEPTIVE COMPOSITION |
1995 |
- Aleksander Dzhejms Bridzhes
- Uilliam Aleksander Dehnni
- Dehvid Fraj
- Alan Krejker
- Robert Majer
- Gordon Uilliam Rukasl
- Andru Mark Tompson
- Khauard Dehniel Khollis Shoualter
|
RU2158127C2 |
DERIVATIVES OF 1,3-SUBSTITUTED CYCLOALKENE AND CYCLOALKANE AS A MIXTURE OF ISOMERS OR INDIVIDUAL ISOMERS OR THEIR HYDRATES, OR SALTS |
1992 |
- Bredlej Villiam Kehpres
- Dennis Majkl Dauning
- Khuan Karlos Dzhejn
- Stifen Dzhozef Dzhonson
- Villiam Dzhon Iii Smit
- Lourens Dejvid Vajs
- Dzhonatan Rajt
- Dejvid Dzhjurgen Vjustro
|
RU2116297C1 |
AMINOACETIC ACID DERIVATIVES AS RACEMATES OR D-AND L- ENANTIOMERS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, METHOD OF PREPARING D-AND L-ENANTIOMERS OF AMINOACETIC ACID DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND AMINOACETIC ACID D-AND L-ENANTIOMERS AS CINCHONIDINE SALTS |
1993 |
- Vladimir Bajlin[Ua]
- Khuaj Gu Chen[Us]
- Om Prakash Gel'[Us]
- Mark Judzhin Marlatt[Us]
- Dzhon Gordon Topliss[Us]
|
RU2111206C1 |
METHOD OF PRODUCING NAPHTHYRYDINE QUINOLINE- OR BENZOXAZINE CARBOLIC ACIDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS OF ACID ADDITION |
0 |
- Taunli P.Kulbertson
- Dzhon M.Domagala
- Tomas F.Mich
- Dzheffri B.Nikols
|
SU1360584A3 |
DERIVATIVES OF 3-ALKYLHYDROXY-, ARYLHYDROXY- OR ARYLALKYLHYDROXY[B]THIOPHENE-2-CARBOXAMIDE, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY INHIBITING ADHESION OF LEUKOCYTES TO VASCULAR ENDOTHELIUM |
1993 |
- Dajen Khehrris Boskelli
- Dehvid Tomas Konnor
- Klifford Din Rajt
|
RU2117665C1 |
DERIVATIVES OF INDOLE, THEIR TAUTOMERS, MIXTURES OF THEIR ISOMERS OR SEPARATE ISOMERS AND PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION SHOWING ANTITUMOR OR INHIBITING PROTEIN TYROSINE KINASE ACTIVITY AND METHOD OF INHIBITION OF PROTEIN TYROSINE KINASE-DEPENDING DISEASE OR CONTROL OF ABERRANT GROWTH OF MAMMALIAN OR HUMAN CELLS |
1993 |
- Dobrasin Ehllen Mira
- Shovol'Ter Khovord Dehniel' Khollis
- Denni Uilliehm Aleksander
- Pal'Mer Brajn Desmond
- Rjukasel' Gordon Uilliehm
- Tersel' Moehna
- Tomson Ehndrju Mark
|
RU2155187C2 |